Pharmacokinetics of Piperacillin and Meropenem in ICU Patients

  • STATUS
    Recruiting
  • participants needed
    50
  • sponsor
    Karolinska University Hospital
Send
Updated on 14 March 2022
See if I qualify

Summary

The purpose of the study is to characterize the pharmacokinetics of meropenem and piperacillin in ICU-patients at the time of the first dose administration and to contrast that with the same measurements obtained in the same patient 2-3 days later during the course of ICU treatment.

Details
Condition Antibiotic Pharmacokinetics
Age 18years or above
Treatment Piperacillin/tazobactam, Meropenem
Clinical Study IdentifierNCT05134298
SponsorKarolinska University Hospital
Last Modified on14 March 2022

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patient being treated in one of the participating ICUs and planned to recieve treatment with meropenem or piperacillin
Exclusion Criteria (fullfilling any exlusion criteria means that patient cannot be included
in the study)
Not possible to retrospectively ask the patient or next of kin for consent to take
part in the study or patient or next-of-kin not providing consent
Not posisble to obtain and process blood samples as specified by protocol
Ongoing renal replacement therapy
Patient having received the same antibiotic within the previous 96 h
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.